Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Return on Sales (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Return on Sales for 16 consecutive years, with 0.03% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 5.0% year-over-year to 0.03%, compared with a TTM value of 0.12% through Dec 2025, up 2.0%, and an annual FY2025 reading of 0.12%, up 2.0% over the prior year.
  • Return on Sales was 0.03% for Q4 2025 at Orthofix Medical, up from 0.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.24% in Q4 2022 and bottomed at 0.35% in Q1 2023.
  • Average Return on Sales over 5 years is 0.11%, with a median of 0.1% recorded in 2023.
  • The sharpest move saw Return on Sales crashed -34bps in 2021, then soared 47bps in 2022.
  • Year by year, Return on Sales stood at 0.23% in 2021, then surged by 205bps to 0.24% in 2022, then crashed by -139bps to 0.09% in 2023, then increased by 21bps to 0.07% in 2024, then soared by 64bps to 0.03% in 2025.
  • Business Quant data shows Return on Sales for OFIX at 0.03% in Q4 2025, 0.1% in Q3 2025, and 0.07% in Q2 2025.